5.60
-0.05(-0.88%)
Currency In USD
| Previous Close | 5.65 |
| Open | 5.68 |
| Day High | 5.72 |
| Day Low | 5.56 |
| 52-Week High | 7.63 |
| 52-Week Low | 3.38 |
| Volume | 3.43M |
| Average Volume | 4.07M |
| Market Cap | 1.72B |
| PE | 50.91 |
| EPS | 0.11 |
| Moving Average 50 Days | 4.72 |
| Moving Average 200 Days | 4.89 |
| Change | -0.05 |
If you invested $1000 in MannKind Corporation (MNKD) 10 years ago, it would be worth $372.09 as of October 08, 2025 at a share price of $5.6. Whereas If you bought $1000 worth of MannKind Corporation (MNKD) shares 5 years ago, it would be worth $2,931.94 as of October 08, 2025 at a share price of $5.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care
GlobeNewswire Inc.
Yesterday at 1:00 PM GMT
DANBURY, Conn. and BURLINGTON, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc. The acquisition of scPharmaceuticals is expected to di
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer
GlobeNewswire Inc.
Sep 29, 2025 10:05 AM GMT
MannKind CMO MannKind appoints Dr. Ajay Ahuja as EVP, Chief Medical Officer WESTLAKE VILLAGE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovati
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
GlobeNewswire Inc.
Aug 27, 2025 12:05 PM GMT
Initial collaboration led to Tyvaso DPI®, the first FDA-approved dry powder inhalation treatment for pulmonary hypertensionDANBURY, Conn. and BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that United